AeroVironment heads into its fiscal first-quarter report carrying a narrative that turned notably more complicated after a blowout fourth quarter. Investors are not just checking whether the company beat a number this time. They are checking whether the deceleration management flagged three months ago is playing out as described, or whether it is proving worse or better than advertised. That distinction matters more than the headline print. Consensus calls for $0.32 in earnings on $474.6 million in revenue, which is flat year-over-year on EPS despite 4.4% revenue growth, a sharp comedown from the 31% organic surge and record $642 million in sales the company just posted in the June quarter. The whisper number sits below consensus at $0.27, suggesting the market has already braced for a soft start to the fiscal year rather than expecting an upside surprise. Management essentially told investors to expect exactly this. On the last call, the company guided Q1 FY27 down year-over-year, citing a roughly $30 million hole from the terminated SCAR program plus order timing. That guidance, layered on top of a full-year framework calling for EPS of $3.02 to $3.34 against a current Street estimate of $3.73, positions the market meaningfully above management's own outlook. That gap is the central tension heading into Thursday's release. Either the company needs to show early signs that its full-year guidance was conservative, or analysts need to walk their numbers down toward managements range. The prior call laid out a legitimate bull case buried inside a cautious wrapper. Bookings from LASSO, the $117 million Long-Range Reconnaissance win, the Vapor CLE award, and the Locust naval demonstration all point to a widening addressable market, with the roughly $500 million EHEL decision looming as a near-term catalyst. But Q4 book-to-bill fell to 0.9x, a meaningful step down from the $1.4 billion bookings quarter reported earlier in the year, and this report offers the first real chance to see whether order flow is reaccelerating or continuing to soften. Margin trajectory is the other swing factor. Adjusted EBITDA margin snapped back to 22% in Q4 after bottoming near 9.5% in the September quarter, but that recovery came alongside a disclosed material weakness in internal controls, an $89 million goodwill impairment, and a restated quarter tied to the SCAR termination. Investors will want evidence that the margin recovery is durable and that the control remediation is progressing, not just a one-quarter bounce. Free cash flow is worth watching too, since the company just posted its first positive FCF quarter in over a year, only to guide to negative free cash flow for all of FY27 because of a 77% jump in depreciation and amortization tied to cloud and capacity investments. The market has already rendered a verdict on this uncertainty. The stock has fallen 16% since the last report while the S&P 500 gained roughly 3.5%, a swing of nearly 20 percentage points, and shares now trade well below their 200-day moving average of $216 after sliding from a post-earnings high above $207 to a low near $139. Bearish sentiment has ticked up only slightly to 24.6% from 24.0%, suggesting expectations have reset lower without becoming outright pessimistic. The report now needs to answer a specific question. Was the FY27 guide genuine conservatism after a noisy year, or an early signal that growth is normalizing faster than the pipeline of new franchise wins can offset.